News Sentiment

NSB sentiment intelligence

NeuroScientific Biopharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 9 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.07 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

89/100 classification confidence.

Company focus 9

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.6% over one week, -5.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Neuroscientific Biopharmaceuticals (ASX:NSB) Surges as Neurological Drug Research Returns to Focus

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 89/100 classification
One-week reaction 1.6% Price digesting
Trend fit Trend inactive -5.8% over four weeks
Fair value -15.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 7
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 9
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine 2
smallcaps.com.au 2
Finance News Network 1
BiotechDispatch 1
Moomoo 1
simplywall.st 1
SMH.com.au 1

Event Lens

What the news is about

Classified themes
Market update 8
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-9 of 9